ShangPharma Corp. (SHP) Misses Q4 EPS by 4c; Issues Light FY12 Revs Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts SHP Hot Sheet
Join SI Premium – FREE
ShangPharma Corp. (NYSE: SHP) reported Q4 EPS of $0.21, $0.04 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $31.8 million.
Sees FY2012 revenue of $131.7-$136.2 million, versus the consensus of $140.03 million.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Sees FY2012 revenue of $131.7-$136.2 million, versus the consensus of $140.03 million.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- AbbVie (ABBV) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
